Nov 14 (Reuters) - Exagen Inc XGN.O :
* Q3 REVENUE $14.7 MILLION
* . REPORTS THIRD QUARTER 2022 RESULTS
* QTRLY LOSS PER SHARE $0.47
* INCREASING FULL YEAR 2022 REVENUE GUIDANCE, RANGE OF $40
MILLION
TO $43 MILLION
* NUMBER OF ORDERING HEALTHCARE PROVIDERS TOTALED 2,287 IN
Q3 OF
2022
* Q3 EARNINGS PER SHARE VIEW $-0.73, REVENUE VIEW $9.1
MILLION --
REFINITIV IBES DATA
* FY2022 REVENUE VIEW $38.1 MILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNXbJTNH4
Further company coverage: XGN.O
((Reuters.Briefs@thomsonreuters.com;))